Treats major depressive disorder (MDD). Sold as Desyrel, Oleptro, Raldesy. Every FDA application for this active ingredient: 3 branded and 33 generic.
As of Nov 16, 2026, FDA lists 36 applications for Trazodone Hydrochloride (sold as Desyrel, Oleptro, Raldesy), first approved Dec 24, 1981, with 2 new uses approved and 0 published complete response letters.
| Trazodone HCl | Part D | $185M | +12% | 4,221,283 |
| Raldesy | Part D | $633K | New | 619 |
| Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in ChinaAnxiety Depression, Sleep · Duke Kunshan University | Phase 4 | Recruiting | Apr 27, 2026 |
| A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for InsomniaInsomnia, Insomnia Disorder · University of Pennsylvania | Phase 4 | Recruiting | Apr 21, 2026 |
| Standardized Sleep Bundle for Cardiac Surgery PatientsSleep · Horizon Health Network | Not applicable | Recruiting | Feb 11, 2026 |
| Real-world Clinical Response to Trazodone in Italy, Poland, and RomaniaDepression - Major Depressive Disorder, Cognition Disorders in Old Age · Aziende Chimiche Riunite Angelini Francesco S.p.A | — | Recruiting | Jan 30, 2026 |
| A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP TreatmentHypertension (HTN), Sleep Apnea Syndrome, Obstructive · Beijing Anzhen Hospital | — | Recruiting | Jan 21, 2026 |
| Neurobiological and Genomic Predictors of Relapse in DepressionHealthy, Major Depressive Disorder (MDD) · Mehmet Kemal Arikan | — | Recruiting | Jan 9, 2026 |
| Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD) · Centre Hospitalier St Anne | Phase 2 | Recruiting | Oct 7, 2025 |
| Central Apnea in Heart Failure: Physiological Mechanisms to Inform TreatmentSleep Disordered Breathing, Able Bodied · VA Office of Research and Development | Phase 4 | Recruiting | Oct 7, 2025 |
| Dec 24, 1981 | DesyrelNDA 18207 · New molecular entity | Pragma | 29 | Discontinued |
| Oct 10, 1986 | Trazodone HydrochlorideANDA 70857 | Watson Labs | 25 | Discontinued |
| Oct 10, 1986 | Trazodone HydrochlorideANDA 70858 | Watson Labs | 25 | Discontinued |
| Mar 25, 1987 | Trazodone HydrochlorideANDA 71258 | Apotex | 29 | Marketed |
| Mar 25, 1987 | Trazodone HydrochlorideANDA 71196 | Apotex Inc | 43 | Marketed |
| Dec 11, 1987 | Trazodone HydrochlorideANDA 71524 | Teva Pharms USA | 23 | Marketed |
| Dec 11, 1987 | Trazodone HydrochlorideANDA 71523 | Teva Pharms USA | 23 | Marketed |
| Mar 9, 1988 | Trazodone HydrochlorideANDA 71525 | Pliva | 28 | Marketed |
| Apr 18, 1988 | Trazodone HydrochlorideANDA 71636 | Alvogen | 20 | Discontinued |
| Apr 18, 1988 | Trazodone HydrochlorideANDA 71514 | Alvogen | 17 | Discontinued |
| Feb 2, 1989 | Trazodone HydrochlorideANDA 72192 | Oxford Pharms | 31 | Marketed |
| Feb 2, 1989 | Trazodone HydrochlorideANDA 72193 | Oxford Pharms | 31 | Marketed |
| Apr 30, 1990 | Trazodone HydrochlorideANDA 72483 | Aiping Pharm Inc | 12 | Discontinued |
| Apr 30, 1990 | Trazodone HydrochlorideANDA 72484 | Rising | 12 | Discontinued |
| Feb 27, 1991 | Trazodone HydrochlorideANDA 71405 | Natco | 6 | Discontinued |
| Feb 27, 1991 | Trazodone HydrochlorideANDA 71406 | Natco | 6 | Discontinued |
| Mar 24, 1993 | Trazodone HydrochlorideANDA 73137 | Sun Pharm Industries | 24 | Marketed |
| Apr 30, 1997 | Trazodone HydrochlorideANDA 74357 | Teva | 6 | Discontinued |
| Jun 2, 2009 | Trazodone HydrochlorideANDA 90514 | Pharmobedient | 4 | Discontinued |
| Feb 2, 2010 | OleptroNDA 22411 · New dosage form | Angelini Pharma | 5 | Discontinued |
| Nov 27, 2013 | Trazodone HydrochlorideANDA 202180 | Torrent | 5 | Marketed |
| Sep 8, 2017 | Trazodone HydrochlorideANDA 206923 | Accord Hlthcare | 3 | Marketed |
| Oct 10, 2017 | Trazodone HydrochlorideANDA 205253 | Zydus Pharms | 4 | Marketed |
| Feb 5, 2020 | Trazodone HydrochlorideANDA 204852 | Aurobindo Pharma | 1 | Marketed |
| May 20, 2024 | Trazodone HydrochlorideANDA 211116 | Crossmedika SA | 1 | Marketed |
| Aug 8, 2024 | Trazodone HydrochlorideANDA 218988 | Granules | 1 | Marketed |
| Aug 27, 2024 | Trazodone HydrochlorideANDA 217740 | Graviti Pharms | 1 | Marketed |
| Nov 26, 2024 | RaldesyNDA 218637 · New dosage form | Kamat | 2 | Marketed |
| — | TrialodineANDA 70942 | Quantum Pharmics | 2 | Discontinued |
| — | Trazodone HydrochlorideANDA 70491 | Usl Pharma | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 70492 | Usl Pharma | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 70921 | Quantum Pharmics | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 71112 | Watson Labs | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 71113 | Watson Labs | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 71139 | Am Therap | 0 | Discontinued |
| — | Trazodone HydrochlorideANDA 71140 | Am Therap | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA